Assessing the Efficacy of Different Carrier Systems in Oral Vitamin B12

Status Not yet recruiting

Clinical Trial Summary

Vitamin B12, a vital nutrient, plays a crucial role in red blood cell formation, neurological function, and DNA synthesis. Deficiency in B12 can lead to anemia, neurological symptoms such as tingling or numbness, and cognitive impairment. Oral B12 supplementation serves as an effective strategy to address B12 deficiency, especially for individuals with limited dietary intake or absorption issues. Regular B12 supplementation can help restore body B12 levels, alleviate deficiency-related symptoms, and support overall health and well-being.

Clinical Trial Description

The carrier system in oral vitamin B12 supplements plays a pivotal role in ensuring the stability and efficacy of the supplement. It helps protect the vitamin from degradation in the acidic environment of the stomach, enhancing its bioavailability. Additionally, the carrier system facilitates the transport of vitamin B12 across the gastrointestinal tract, promoting optimal absorption. By optimizing the delivery of B12 to the small intestine, the carrier system maximizes its potential for absorption into the bloodstream. Overall, the choice of carrier system significantly impacts the effectiveness of oral B12 supplementation in addressing deficiency and improving health outcomes. Limited research exists regarding the exploration of various carrier systems used in oral B12 supplementation. This gap hinders a comprehensive understanding of how different carriers affect B12 absorption and efficacy. Further studies are needed to elucidate the optimal carrier system for maximizing B12 bioavailability and improving clinical outcomes. Expanding research in this area can enhance our knowledge and guide the development of more effective oral B12 supplements. This study aims to compare the efficacy of sucrosomial and non-sucrosomial carrier systems in delivering vitamin B12 orally. By assessing absorption kinetics and clinical outcomes, we seek to determine the superiority of the sucrosomial carrier system in enhancing B12 bioavailability. Insights from this research could help in the development of more effective oral B12 supplements. ;

Study Design

Related Conditions & MeSH terms

Vitamin B 12 Deficiency

Clinical Trial Details

NCT number	NCT06376591
Study type	Interventional
Source	Liaquat University of Medical & Health Sciences
Contact
Status	Not yet recruiting
Phase	N/A
Start date	April 22, 2024
Completion date	August 31, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06100146` - Effectiveness of Fortification With Folic Acid and Vitamin B12 Among Teenage Girls	N/A
Completed	`NCT04083560` - A Comparison of Two Different Doses of Maternal B12 Supplementation in Improving Infant B12 Deficiency and Neurodevelopment	N/A
Completed	`NCT04632771` - Nutritional Status and Bouillon Use in Northern Ghana
Active, not recruiting	`NCT03853304` - Quadruple Fortified Salt Trial in India	N/A
Completed	`NCT03437824` - Effects of Vitamin B12 Treatment in Singers	Early Phase 1
Active, not recruiting	`NCT05315843` - Cobalamin Supply and Metabolism in Healthy Children From Birth to the Age of 12 Months and in Their Mothers (Cbl_Neo)
Completed	`NCT05614960` - Dried Purple Laver (Nori) as a Food Source of Vitamin B12 in Vegetarians	N/A
Completed	`NCT03444155` - Natural Versus Synthetic Vitamin B Complexes in Human	N/A
Enrolling by invitation	`NCT05389618` - Dietary Challenges in the Population of Nursing Homes' Residents
Completed	`NCT01832129` - Vitamin B12 Acceptance and Biomarker Response Study	Phase 4
Completed	`NCT03365583` - The Impact of Vitamin B12 Deficiency on Infant Gut Microbiota
Active, not recruiting	`NCT03071666` - Vitamin B12 Supplementation During Pregnancy on Cognitive Development	Phase 2/Phase 3
Active, not recruiting	`NCT05426395` - Vitamin B12 Dose Escalation Trial in Pregnancy	Phase 1
Completed	`NCT00710138` - Cobalamin Status in Young Children With Developmental Delay	N/A
Completed	`NCT03284840` - Adults Nutrition as a Protective or Health-risk Factor
Not yet recruiting	`NCT06441721` - Vitamin B12 Status and Its Impact on Chronic Haemodialysis Patient
Completed	`NCT01476007` - Oral/Intramuscular B12 to Treat Cobalamin Deficiency	N/A
Completed	`NCT03447275` - The Vitamin B Status in Type 2 Diabetes (VITA) Study
Completed	`NCT02860338` - COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICE	N/A
Active, not recruiting	`NCT05178407` - Effect of Household Use of Multiple Micronutrient-fortified Bouillon on Micronutrient Status Among Women and Children in Two Districts in the Northern Region of Ghana	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Assessing the Efficacy of Different Carrier Systems in Oral Vitamin B12 Supplementation in Healthy Adults With B12 Deficiency

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms